I emailed CCFA on the subject, this was their response.
Thank you for contacting the Crohn’s & Colitis Foundation of America (CCFA) through your recent email regarding MAP. I understand you would like CCFA to consider support for an anti-Map vaccine. Please review the information below and attached.
CCFA is well aware of MAP. We have major research projects studying enormously complex bacteria, viruses, and fungi. This study is known as our Microbiome Initiative. To learn more about this project visit
http://www.ccfa.org/science-and-pro...t-research-studies/microbiome-initiative.html
MAP is more frequently recovered from the intestines of patients with Crohn’s disease compared to people with ulcerative colitis and individuals without either disease.
However, several findings have caused many researchers to discount a causative role for MAP in Crohn’s disease. First, MAP cannot be detected in many patients with Crohn’s disease and has been frequently found growing in people without the disease. Second, medical therapy specifically targeted against MAP does not consistently alleviate the symptoms or eradicate the inflammation associated with Crohn’s disease. Third, other medical therapies that suppress the immune system (e.g., immunosuppressants) or target specific inflammatory proteins (e.g., biologic agents) are effective in Crohn’s disease, but would likely be associated with no improvement or worsening of disease caused by MAP. Most clinicians accordingly believe that MAP may be a part of the normal intestinal bacterial flora of many people exposed to this organism through common food sources, but is present in greater quantities in patients with Crohn’s disease because of the underlying immune dysfunction. Clinical trials studying MAP and Crohn’s disease are ongoing.
In summary, Mycobacterium avium paratuberculosis may play a role in the development of Crohn’s disease as one of many different microbes that might act as a trigger for an abnormal inflammatory response in genetically susceptible individuals. But until more convincing scientific proof emerges, it cannot be described as a primary or the sole cause of Crohn’s disease.
Dr. John Herman Taylor of England and any researcher is able to request support by contacting CCFA at:
http://www.ccfa.org/science-and-professionals/research/grants-fellowships/
Thank you for reaching out to us! If you have further questions, please email CCFA or call our toll-free number at 1.888.694.8872, Monday through Friday 9am-5pm EST to speak with an information specialist.
I kindly responded with my opinion below.
However, several findings have caused many researchers to discount a causative role for MAP in Crohn’s disease. First, MAP cannot be detected in many patients with Crohn’s disease and has been frequently found growing in people without the disease.
MAP has historically been a difficult mycobacteria to culture. It cannot be seen under a microscope. Only using proper analytical techniques can it be verified. Studies have proved this. In the Journal of Clinical Microbiology, a study was done which determined 92% of Crohns Disease Patients to have MAP, vs 26% of control using PCR.
http://jcm.asm.org/content/41/7/2915.full.pdf
Secondly, just because you are not showing symptoms of IBD, DOES NOT mean you are not infected. The MAP present may not be in an active disease state. H Pylori, for example, is well known to cause asymptomatic state, mild gastritis, stomach ulcers, and stomach cancer. YOU MUST TAKE THIS INTO ACCOUNT. Also, different people have different biochemistries and different genes and react differently to different things. Just because somebody has MAP in their system and is not showing active symptoms of IBD DOES NOT prove that MAP doesn’t cause Crohns.
Second, medical therapy specifically targeted against MAP does not consistently alleviate the symptoms or eradicate the inflammation associated with Crohn’s disease.
So because anti-biotic therapy against MAP doesn’t cure Crohns patients at a rate of 100% means MAP doesn’t cause Crohns? Koch Postulates have already shown that MAP causes Crohns, as well as Relman’s criteria. That is, MAP isolated from a Crohns patient was injected into a healthy animal which subsequently become sick with Johnes Disease.
http://www.ncbi.nlm.nih.gov/pubmed/3803136
People build up resistance to antibiotics. They are not a cure. And MAP is known to be hard to kill and resistant to anti-mycobacterial drugs.
Third, other medical therapies that suppress the immune system (e.g., immunosuppressants) or target specific inflammatory proteins (e.g., biologic agents) are effective in Crohn’s disease, but would likely be associated with no improvement or worsening of disease caused by MAP.
I’m sorry, but you’re wrong. If you were to treat a patient with Mycobacterium leprae (a mycobacteria more closely related to MAP) with a biologic drug, they would NOT get worse. Mycobacterium Tuberculosis is an exception not the norm.
http://www.cdd.com.au/pdf/publicati...eases Piecing the Crohn's Puzzle together.pdf
Most clinicians accordingly believe that MAP may be a part of the normal intestinal bacterial flora of many people exposed to this organism through common food sources, but is present in greater quantities in patients with Crohn’s disease because of the underlying immune dysfunction.
So why is it not as present in Pure Ulcerative Colitis? UC’ers have an immune dysfunction, but the bug is not found nearly as much in them as it is in Crohns patients.
http://www.ncbi.nlm.nih.gov/pubmed/15951529
Clinical trials studying MAP and Crohn’s disease are ongoing.
Yes, and CCFA should be at the forefront of this research! You guys represent us, you are the ones with the voices that can reach people that can make a difference. That difference is right here, this is it!